877
Views
14
CrossRef citations to date
0
Altmetric
Author's View

A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?

, &
Article: e23850 | Received 28 Jan 2013, Accepted 31 Jan 2013, Published online: 01 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mekonnen Sisay, Getnet Mengistu & Dumessa Edessa. (2017) The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy. OncoTargets and Therapy 10, pages 3801-3810.
Read now

Articles from other publishers (13)

Daniela Damiani & Mario Tiribelli. (2022) Present and Future Role of Immune Targets in Acute Myeloid Leukemia. Cancers 15:1, pages 253.
Crossref
V. A. Shiva Ayyadurai, Prabhakar Deonikar, Kevin G. McLure & Kathleen M. Sakamoto. (2022) Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment. Cancers 14:3, pages 756.
Crossref
Débora Bifano Pimenta, Vanessa Araujo Varela, Tarcila Santos Datoguia, Victória Bulcão Caraciolo, Gabriel Herculano Lopes & Welbert Oliveira Pereira. (2021) The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology 9.
Crossref
Wenbin Zhao, Yuanfeng Liu, Kang Liu, Feng Tu, Chen Zhang & Hao Wang. (2021) Synovial fibroblasts regulate the cytotoxicity and osteoclastogenic activity of synovial natural killer cells through the RANKL‐RANK axis in osteoarthritis. Scandinavian Journal of Immunology 94:2.
Crossref
Aristofania Simatou, Panagiotis Sarantis, Evangelos Koustas, Athanasios G. Papavassiliou & Michalis V. Karamouzis. (2020) The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL. International Journal of Molecular Sciences 21:20, pages 7570.
Crossref
Jasna Metovic, Laura Annaratone, Alessandra Linari, Simona Osella-Abate, Chiara Musuraca, Francesca Veneziano, Chiara Vignale, Luca Bertero, Paola Cassoni, Nicola Ratto, Alessandro Comandone, Giovanni Grignani, Raimondo Piana & Mauro Papotti. (2020) Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone. Cancer Immunology, Immunotherapy 69:9, pages 1905-1916.
Crossref
E. E. Ladikou, H. Sivaloganathan, A. Pepper & T. Chevassut. (2020) Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia. Current Oncology Reports 22:3.
Crossref
Peter A. van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma, Filip Lardon, Tim Van den Wyngaert, Jonatan Dewulf, Evelien Smits, Cécile Colpaert, Hans Prenen, Marc Peeters, Martin Lammens & Xuan Bich Trinh. (2019) RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. International Journal of Molecular Sciences 20:9, pages 2183.
Crossref
Kim Clar, Clemens Hinterleitner, Pascal Schneider, Helmut Salih & Stefanie Maurer. (2019) Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL. Cancers 11:3, pages 277.
Crossref
Manar S Shafat, Bruno Gnaneswaran, Kristian M Bowles & Stuart A Rushworth. (2017) The bone marrow microenvironment – Home of the leukemic blasts. Blood Reviews 31:5, pages 277-286.
Crossref
Joerg Uwe Schmohl, Tina Nuebling, Julia Wild, Tanja Kroell, Lothar Kanz, Helmut Rainer Salih & Helga Schmetzer. (2016) Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosis. European Journal of Haematology 97:6, pages 517-527.
Crossref
Eva González-Suárez & Adrián Sanz-Moreno. (2016) RANK as a therapeutic target in cancer. The FEBS Journal 283:11, pages 2018-2033.
Crossref
Paolo Bernasconi, Mirko Farina, Marina Boni, Irene Dambruoso & Celeste Calvello. (2016) Therapeutically targeting SELF ‐reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor? . American Journal of Hematology 91:5, pages 507-517.
Crossref